When should metformin be discontinued prior to a planned knee surgery?

When to Stop Metformin for Knee Surgery

Stop metformin the night before knee surgery and do not restart until at least 48 hours postoperatively after confirming adequate renal function. 1

Timing of Discontinuation

The 2018 perioperative management guidelines for diabetic patients provide clear direction on metformin cessation:

• Discontinue metformin the evening before surgery (not 48 hours prior as older protocols recommended) 1
• This applies to major surgery, which includes knee surgery 1
• For minor or ambulatory procedures, metformin may be continued except in cases of severe renal failure 1

Critical Risk Assessment Before Surgery

Before proceeding, assess for risk factors that increase lactic acidosis risk (mortality rate 30-50%): 1

• Renal impairment: creatinine clearance < 60 mL/min 1
• Severe heart failure: left ventricular ejection fraction < 30% 1
• Conditions impairing renal function: dehydration, fasting, concurrent use of ACE inhibitors, sartans, diuretics, or NSAIDs 1
• Planned iodinated contrast administration 1

The presence of these factors mandates metformin discontinuation and delays reintroduction postoperatively. 1

Postoperative Restart Protocol

Do not restart metformin for at least 48 hours after major surgery and only after confirming: 1

• Adequate renal function has been verified
• Patient is hemodynamically stable
• No acute kidney injury has developed
• Normal oral intake has resumed

Evidence Quality and Nuances

The guideline recommendations 1 represent a shift from older protocols that required 48-hour preoperative discontinuation. 2, 3 This change reflects accumulating evidence that metformin-associated lactic acidosis occurs primarily when contraindications are ignored, not from metformin itself. 1

Recent research supports this more liberal approach:

• A 2019 CABG study found continuation until the night before surgery did not increase lactate levels or lactic acidosis rates 4
• A 2018 RCT showed continuation during non-cardiac surgery did not raise lactate to clinically relevant levels 5

However, the FDA drug label 6 emphasizes stopping metformin for procedures where patients cannot eat or drink, and the risk remains real with a 20% mortality rate in French surveillance data when lactic acidosis occurs. 1

Common Pitfalls to Avoid

• Do not continue metformin in patients with eGFR < 60 mL/min approaching surgery 1
• Do not restart prematurely before confirming stable renal function postoperatively 1
• Do not overlook concurrent nephrotoxic medications (NSAIDs, ACE inhibitors) that compound risk 1
• Do not assume all surgeries require the same approach—minor/ambulatory procedures have different recommendations 1